CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy

被引:0
作者
Kranz, Lena M. [1 ]
Beck, Jan D. [2 ]
Grunwitz, Christian [1 ]
Hotz, Christian [1 ]
Vormehr, Mathias [3 ,4 ]
Diken, Mustafa [2 ]
机构
[1] BioNTech RNA Pharmaceut GmbH, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz gGmbH, Univ Med Ctr, TRON Translat Oncol, Mainz, Germany
[3] BioNTech AG, Mainz, Germany
[4] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany
关键词
antibodies; CIMT; cancer immunotherapy; cellular therapy; checkpoint blockade; combination therapy; personalized therapy; tumor microenvironment; tumor vaccination; NATURAL-KILLER-CELLS; SYNTHETIC DENDRITIC CELLS; MOLONEY LEUKEMIA-CELLS; CD4(+) T-CELLS; IMMUNE-RESPONSES; PD-1; BLOCKADE; THERAPEUTIC ANTIBODY; METASTATIC MELANOMA; CHECKPOINT BLOCKADE; CLINICAL-RESPONSE;
D O I
10.1080/21645515.2017.1340138
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:2272 / 2279
页数:8
相关论文
共 74 条
[1]  
Al-Batran S.-E., 2016, J. Clin. Oncol, V34, DOI [10.1200/JCO.2016.34.18_suppl.LBA4001, DOI 10.1200/JCO.2016.34.18SUPPL.LBA4001, 10.1200/JCO.2016.34.18suppl.LBA4001]
[2]   CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC [J].
Antonia, Scott J. ;
Gettinger, Scott N. ;
Goldman, Jonathan ;
Brahmer, Julie ;
Borghaei, Hossein ;
Chow, Laura Q. ;
Ready, Neal E. ;
Gerber, David E. ;
Juergens, Rosalyn ;
Shepherd, Frances ;
Laurie, Scott A. ;
Young, Tina ;
Geese, William J. ;
Agrawal, Shruti ;
Li, Xuemei ;
Hellmann, Matthew D. .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) :S250-S251
[3]   Immune checkpoint blockade in hematologic malignancies [J].
Armand, Philippe .
BLOOD, 2015, 125 (22) :3393-3400
[4]   The "cancer immunogram" [J].
Blank, Christian U. ;
Haanen, John B. ;
Ribas, Antoni ;
Schumacher, Ton N. .
SCIENCE, 2016, 352 (6286) :658-660
[5]   The CIMT-monitoring panel:: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays [J].
Britten, C. M. ;
Gouttefangeas, C. ;
Welters, M. J. P. ;
Pawelec, G. ;
Koch, S. ;
Ottensmeier, C. ;
Mander, A. ;
Walter, S. ;
Paschen, A. ;
Mueller-Berghaus, J. ;
Haas, I. ;
Mackensen, A. ;
Kollgaard, T. ;
thor Straten, P. ;
Schmitt, M. ;
Giannopoulos, K. ;
Maier, R. ;
Veelken, H. ;
Bertinetti, C. ;
Konur, A. ;
Huber, C. ;
Stevanovic, S. ;
Woelfel, T. ;
van der Burg, S. H. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (03) :289-302
[6]   Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population [J].
Brzezianska, Ewa ;
Karbownik, Malgorzata ;
Migdalska-Sek, Monika ;
Pastuszak-Lewandoska, Dorota ;
Wloch, Jan ;
Lewinski, Andrzej .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 599 (1-2) :26-35
[7]   Exploiting the Mutanome for Tumor Vaccination [J].
Castle, John C. ;
Kreiter, Sebastian ;
Diekmann, Jan ;
Loewer, Martin ;
Van de Roemer, Niels ;
de Graaf, Jos ;
Selmi, Abderraouf ;
Diken, Mustafa ;
Boegel, Sebastian ;
Paret, Claudia ;
Koslowski, Michael ;
Kuhn, Andreas N. ;
Britten, Cedrik M. ;
Huber, Christoph ;
Tuereci, Oezlem ;
Sahin, Ugur .
CANCER RESEARCH, 2012, 72 (05) :1081-1091
[8]   Immune checkpoints on innate lymphoid cells [J].
Chiossone, Laura ;
Vivier, Eric .
JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (06) :1561-1563
[9]   Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes [J].
Cohen, Cyrille J. ;
Gartner, Jared J. ;
Horovitz-Fried, Miryam ;
Shamalov, Katerina ;
Trebska-McGowan, Kasia ;
Bliskovsky, Valery V. ;
Parkhurst, Maria R. ;
Ankri, Chen ;
Prickett, Todd. D. ;
Crystal, Jessica S. ;
Li, Yong F. ;
El-Gamil, Mona ;
Rosenberg, Steven A. ;
Robbins, Paul F. .
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (10) :3981-3991
[10]   Primary antitumor immune response mediated by CD4+ T cells [J].
Corthay, A ;
Skovseth, DK ;
Lundin, KU ;
Rosjo, E ;
Omholt, H ;
Hofgaard, PO ;
Haraldsen, G ;
Bogen, B .
IMMUNITY, 2005, 22 (03) :371-383